BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Adamis Urges Shareholders to Maintain Momentum with Current Board

  Adamis has sent a letter to stockholders urging them to re-elect all the five board members as part of a strategic move to continue and maintain its current growth initiatives.

  June 28, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Swiss Biopharma’s Future Threatened After Cancer Drug Study Fails to Meet Goals

  Polyphor said there has been no improvement in the results for FORTRESS, its Phase III global study for the possible treatment of patients with breast cancer.

  June 28, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Promised EAP Date Approaching for Biogen’s Highly Publicized ALS Drug

  Tofersen is the furthest along of four ASOs currently in clinical development for ALS and as such, there is quite a bit riding on the results of the VALOR trial which has an estimated completion date of August 31st, 2021.

  June 28, 2021

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Study: Low-Intensity, Non-Invasive Ultrasound Treatment for Alzheimer’s Disease

  Australian scientists may have found a way to treat Alzheimer’s disease using non-invasive methods. Here’s everything about the ultrasound treatment for Alzheimer’s.

  June 28, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  AstraZeneca Taps Susan Galbraith to Take Over as Head of Oncology R&D

  She takes over the role held by oncology research legend José Baselga, who passed away in March from a neurodegenerative disease.

  June 28, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Lilly, Novo Nordisk Present Promising Data in Type 2 Diabetes

  Eli Lilly and Novo Nordisk published their data in The Lancet Diabetes & Endocrinology and presented them at the ADA conference.

  June 28, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  COVID-19 News: Delta Variant a Cause for Concern and Other Topics

  Although the COVID-19 pandemic is waning in the U.S., it’s not completely over and there are some concerns, particularly with the delta variant, which originated in India. Here’s a look.

  June 28, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Job Trends

  AstraZeneca, Sanofi’s Monoclonal RSV Antibody Shows Promising Safety in Infants

  The trial is the third study in a set of pivotal trials to report positive data for the therapy.

  June 28, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Policy

  Aduhelm Saga Continues as Lawmakers Plan to Investigate Approval, Pricing

  The House Committee on Oversight and Reform announced plans to investigate the approval and pricing of the drug. Biogen, on its part, has defended its pricing.

  June 28, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  AskBio, Syndax and Catalyst All on the Fast Track

  The U.S. FDA granted Fast Track Designation to three biopharma companies for the treatment of LGMD, episodic bleeding and leukemia.

  June 28, 2021

   · 

  3 min read

   · 

  Alex Keown